GlassScriptPhysician profile
Bret M Schipper
NPI 1821296500
$14,782.09
in general payments reported to CMS, 2019-2025
13 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $463 · 2021: $227 · 2022: $71.39 · 2023: $1,556 · 2024: $67.77 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $437 · Travel and Lodging: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,063.43 |
| Food and Beverage | $437.32 |
| Travel and Lodging | $402.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,431.29 | 2021-2025 | |
| Baxter Healthcare | $1,315.29 | 2023-2025 | Tisseel, Floseal |
| Intuitive Surgical, INC. | $490.92 | 2020-2021 | |
| Ethicon INC. | $155.72 | 2020-2021 | |
| Olympus America INC. | $111.75 | 2023 | |
| Abbott Laboratories | $85.07 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $62.14 | 2025 | |
| Fujifilm Healthcare Americas Corporation | $38.38 | 2023 | Arietta Precision |
| E.R. Squibb & Sons, L.L.C. | $32.39 | 2019 | |
| Leo Pharma INC. | $25.17 | 2024 | Adbry |
| Merck Sharp & Dohme LLC | $17.56 | 2023 | Keytruda |
| Smith+Nephew, INC. | $16.41 | 2024 | Stravix, Grafix |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Schipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.